Company intelligence / Profile preview

Beijing QS Medical Technology

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Beijing QS Medical Technology has developed and commercialized needle-free injector devices for various medical applications. Their products have received CFDA registration and CE Mark certification. Clinical trial reports have been published in leading journals. The company's injectors are used for insulin, vaccines, interferon, anesthetics and more. They are recognized for improving patient comfort by eliminating needles and increasing medication absorption

Therapeutic areas: EndocrinologyInfectious DiseasesOther
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Collaborations with major hospitals in China including those in Beijing, Shanghai and Guangzhou for clinical research on needle-free dosing systems

Beyond the preview

Go deeper on Beijing QS Medical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing QS Medical Technology.

Explore the full profile